The Remaining strength is a sizable portfolio footprint which can continue to negotiate with exterior manufacturers. If US incentives extend for community drug substance do the job, Viatris may have partnerships as an alternative to owned assets to qualify. The key operational chance is supplier concentration and slower remediation cycles https://www.tjcy.com/industry-information/api-vs-fdf-vs-intermediates-what-s-the-difference.html